← FDA Drug Approvals (Drugs@FDA)
EMPAGLIFLOZIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2026-09-22
Drug application
- FDA Application #
ANDA212330- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EMPAGLIFLOZIN
- Generic name
- Empagliflozin
- Active ingredients
- EMPAGLIFLOZIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- INVAGEN PHARMS
- First approval
- 2026-09-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown